lulupedia
Norræna 版本暂未收录,当前展示 English 内容。

Β-Lactam

7206 words·9/24/2026·English
3

A β-lactam (beta-lactam) is a four-membered cyclic amide, formally derived from the intramolecular condensation of a β-amino acid. The parent compound is 2-azetidinone (azetidin-2-one), with the chemical formula C₃H₅NO. The β-lactam functional group is best known as the central pharmacophore of the β-lactam antibiotics, including penicillins, cephalosporins, carbapenems, and monobactams. Because the four-membered ring contains an amide bond with considerable angular strain and reduced amide resonance, β-lactams are much more reactive toward nucleophilic ring-opening than ordinary amides, a property that is fundamental to both their antibacterial mechanism and their use in synthetic chemistry.

Structure and nomenclature

The β-lactam ring is a four-membered lactam. In systematic nomenclature, the parent heterocycle is called 2-azetidinone or azetidin-2-one. The ring is numbered with the nitrogen as position 1, the carbonyl carbon as position 2, and the two remaining carbon atoms as positions 3 and 4. The name “β-lactam” refers to the relationship in the parent β-amino acid; for example, cyclization of β-alanine gives the azetidin-2-one skeleton.

The unsubstituted ring is small and highly strained. In an ordinary acyclic secondary amide, the nitrogen lone pair donates electron density into the carbonyl group, producing partial carbon–nitrogen double-bond character and a strong preference for a planar arrangement. This delocalization is geometrically restricted in a four-membered ring, so the nitrogen atom is more pyramidal and the carbonyl is less stabilized by resonance. As a result, the infrared carbonyl stretching frequency of β-lactams is typically about 1740–1780 cm⁻¹, significantly higher than the 1650–1680 cm⁻¹ commonly observed for ordinary secondary amides. The ring strain and diminished resonance make the carbonyl carbon more electrophilic.

Substitution at C3 and C4 can produce cis/trans diastereomers. In fused bicyclic antibiotics, the stereochemistry is fixed by the fused ring system. Many natural and synthetic β-lactams are N-substituted, which further modulates their stability and reactivity.

Chemical properties and reactivity

The most characteristic reaction of β-lactams is nucleophilic ring opening at the carbonyl carbon. Hydrolysis under acidic or basic conditions yields the corresponding β-amino acid or its salt. Alcoholysis and aminolysis produce β-amino esters and β-amino amides, respectively. These reactions proceed much more rapidly than the corresponding reactions of ordinary amides because of the release of ring strain and the reduced resonance stabilization of the starting amide.

In β-lactam antibiotics, this reactivity is directed toward a specific biological target: the carbonyl group undergoes acylation by an active-site serine residue in penicillin-binding proteins (PBPs), forming a covalent enzyme–acyl complex. Ordinary amides would not acylate such enzymes efficiently under physiological conditions, but the strained β-lactam does.

The stability of a β-lactam in aqueous solution depends on substitution, pH, and the presence of fused rings. Penicillins, for example, are acid-sensitive and can undergo rearrangement, while cephalosporins and carbapenems differ in their susceptibility to chemical and enzymatic hydrolysis.

Synthesis

The most widely used laboratory method for constructing β-lactams is the Staudinger synthesis, in which a ketene reacts with an imine in a formal [2+2] cycloaddition. The reaction can be performed with a wide range of ketenes and imines and is often stereoselective, making it valuable for preparing substituted azetidin-2-ones.

Other approaches include cyclization of β-amino acid derivatives, such as β-amino esters or activated β-amino carboxylic acid derivatives, and the Kinugasa reaction, a copper-catalyzed coupling of nitrones with terminal alkynes that yields β-lactams. Industrial production of β-lactam antibiotics generally relies on fermentation for natural products, such as penicillin G, followed by semisynthetic modification, or on total synthesis for certain carbapenems and monobactams.

Natural occurrence and biological role

The β-lactam ring occurs in a variety of natural products, most famously in antibiotics produced by fungi and bacteria. Penicillins are produced by Penicillium species and contain a β-lactam ring fused to a five-membered thiazolidine ring, forming the penam nucleus. Cephalosporins and cephamycins contain a β-lactam fused to a six-membered dihydrothiazine ring, forming the cephem nucleus, and are produced by Acremonium and Streptomyces species. Carbapenems, such as thienamycin, are produced by Streptomyces and contain an unsaturated five-membered ring fused to the β-lactam. Monobactams, such as nocardicin, are monocyclic β-lactams.

Clavulanic acid, produced by Streptomyces clavuligerus, is a β-lactam-containing compound that has only weak antibacterial activity but is a potent inhibitor of many β-lactamase enzymes. The 2-azetidinone scaffold is also found in synthetic drugs unrelated to antibacterial action, such as ezetimibe, a cholesterol absorption inhibitor.

β-Lactam antibiotics

The β-lactam antibiotics are among the most widely used classes of antibacterial agents. They act by inhibiting bacterial cell wall biosynthesis. Specifically, they mimic the D-alanyl-D-alanine terminus of peptidoglycan precursors and covalently bind the active-site serine of penicillin-binding proteins, enzymes involved in cross-linking peptidoglycan strands. Irreversible inhibition leads to weakening of the cell wall, cell lysis, and bacterial death.

Major subclasses include:

  • Penicillins (penams): β-lactam fused to a thiazolidine ring; examples include penicillin G, amoxicillin, ampicillin, and piperacillin.
  • Cephalosporins and cephamycins (cephems): β-lactam fused to a dihydrothiazine ring; examples include cefazolin, ceftriaxone, cefepime, and cefoxitin.
  • Carbapenems: β-lactam fused to an unsaturated five-membered ring lacking sulfur; examples include imipenem, meropenem, and ertapenem. They have a very broad antibacterial spectrum and are often reserved for serious infections.
  • Monobactams: monocyclic β-lactams; aztreonam is the principal clinical example and has activity primarily against aerobic Gram-negative bacteria.

The structural diversity among these classes affects spectrum of activity, susceptibility to β-lactamases, pharmacokinetics, and adverse effects. Allergy to penicillins is a well-known clinical concern, with cross-reactivity among β-lactams varying by side-chain structure and class.

β-Lactamases and inhibitors

Resistance to β-lactam antibiotics is most commonly mediated by β-lactamases, bacterial enzymes that hydrolyze the β-lactam ring and inactivate the drug. Serine β-lactamases use an active-site serine to open the ring, forming an acyl-enzyme intermediate that is rapidly hydrolyzed. Metallo-β-lactamases use one or two zinc ions to activate water for hydrolysis.

To overcome this resistance, β-lactam antibiotics are frequently combined with β-lactamase inhibitors. Clavulanic acid, sulbactam, and tazobactam are themselves β-lactam compounds that act as irreversible or “suicide” inhibitors of many serine β-lactamases; they are co-administered with partners such as amoxicillin, ampicillin, or piperacillin. Newer inhibitors, including avibactam, relebactam, and vaborbactam, are structurally distinct from classical β-lactams and extend inhibition to some β-lactamases that degrade older combinations.

History

Penicillin was discovered by Alexander Fleming in 1928, and its development by Howard Florey, Ernst Chain, and colleagues during World War II established the first clinically useful β-lactam antibiotic. The β-lactam ring of penicillin was confirmed in the 1940s by X-ray crystallography, principally through the work of Dorothy Hodgkin. The recognition that a strained four-membered cyclic amide could serve as a selective antibacterial warhead stimulated decades of synthetic and medicinal chemistry, leading to the cephalosporins, carbapenems, monobactams, and β-lactamase inhibitors in use today.

Comments (0)

U

No comments yet. Be the first to comment!

Related Articles